Consumer

Holista Colltech Limited (ASX:HCT)

Industry Group : Household & Personal Products | Industry Group Name : Personal Products

Market Price : AUD 0.058-0.001 (1.695%)

(as on 2021-10-26 10:51:20)

Market Cap : AUD 15.97 M

Previous Close Open Close* Day Range 52 WEEK HIGH LOW
0.059 0.058 0.058 0.058L 0.058 H 0.048L 0.095 H
Last Trade 0.058
Change% -1.6949
52 W H/L 0.095/0.048
EBITDA -1.103 M
NPAT After Abnormal Items -5.483 M
Equity 4.644 M
ROE% -83.28%
Total Liabilities 3.409 M
Total Revenue 7.452 M
Cash and Cash Equivalents 2.725 M

Stock Information

Share price 0.058
Market Cap 15.97 M
Price/Gross Cash Flow -6.64
Dividend Yield Excluding Special 0.00%
Ending Shares 275.349 M
52-Week Range 0.048-0.095
P/E ratio 0.000
Sector P/E --
EPS -2.02
EV/EBITDA --
Net Profit Margin (%) -63.52%
Gross Cash Flows Per Share -0.01
Net Gearing -38.39%
Gross DPS (AUD) 0
Gross Dividend Yield (Annualized) 0.00%
Earnings Yield 0.000
Net Tangible Asset (NTA) 0.02
Sales Per Share 0.03
Book Value Per Share 0.02

Announcements

Heading Date/Time
Holista Signs Term Sheet with Berjaya Country Farms  12/10/2021 11:45AM
Trading Halt  11/10/2021 10:39AM
Pause in Trading  11/10/2021 9:55AM
Natshield Receives Trademark Approval for Sales in China  16/09/2021 9:34AM
Change of Company Secretary and Registered Office  01/09/2021 5:41PM
Holista Delivers Improved Interim Revenue and Profit  27/08/2021 10:56AM
Appendix 4D and Interim Financial Report  27/08/2021 10:55AM
Pause in Trading  27/08/2021 9:59AM
Court Proceeding  05/08/2021 1:18PM
Trading Halt  04/08/2021 9:35AM
Initial Director's Interest Notice  03/08/2021 4:52PM
Final Director's Interest Notice  03/08/2021 4:52PM
Results of 2021 Annual General Meeting  30/07/2021 5:34PM
Board Changes  30/07/2021 12:38PM
AGM Presentation  30/07/2021 12:35PM
Quarterly Activities Report and Appendix 4C  28/07/2021 9:33AM
Results of Share Sale Facility for Unmarketable Parcels  09/07/2021 9:34AM
Notice of Annual General Meeting / Proxy Form  30/06/2021 11:18AM
Final Director's Interest Notice  28/06/2021 12:27PM
Final Director's Interest Notice  28/06/2021 12:21PM
Initial Director's Interest Notice  28/06/2021 12:17PM
Board Changes  28/06/2021 12:08PM
Update on Legal Dispute  23/06/2021 11:57AM
Maiden Order for SARS-CoV-2 test kits in Malaysia  18/06/2021 12:03PM
State Grant Secured to Produce Medical Grade Collagen  26/05/2021 11:18AM
Reinstatement to Official Quotation  26/05/2021 9:32AM
Collagen Market Update - Further Information  26/05/2021 9:31AM
Extension of existing voluntary suspension  25/05/2021 9:30AM
Extension of existing voluntary suspension  24/05/2021 9:07AM

Similar Companies

Related Articles

Load More

About Company

Holista Colltech Limited (ASX:HCT) is a research-driven Australian biotech company engaged in developing, manufacturing and marketing various health and wellness products. It was created by the merger of Holista Biotech Sdn Bhd and CollTech Australia Ltd. 

Besides providing first-class natural ingredients and wellness products, the Company also leads in research on food ingredients and herbs. Holista′s suite of offerings caters to the unmet and expanding needs of natural medicine. The Company has a presence in Australia, Asia, and the US, with extensive operations in Malaysia.

Key business divisions of Holista include Healthy Food Ingredients, Infection Control Solutions, Dietary Supplements and Ovine Collagen. 

Healthy Food Ingredients

Holista has a full range of low Glycemic Index (GI) foods such as low GI Bread, low GI noodles and Spaghetti, tested and validated by the University of Sydney. Low GI food is helpful in controlling blood glucose levels. In addition, the Company’s 80Less™ sugar having a 99% taste profile of sugar with 80% fewer calories, along with its low-fat chip, offers customers healthier food choices. 

Infection Control Solutions

NatShieldTM Spray developed from Path-Away® is a powerful killer of over 170 viruses, fungi, and bacteria naturally without side effects.

Path-Away® is a plant-based solution that is proven to kill a broad spectrum of microbes. Microbac tests have indicated that Path-Away® kills 99.9% of the COVID-19 virus within two minutes, as per the Company. 

The all-natural alcohol-free active ingredient is used in the ompany’s range of disinfectant products under the NatShield™ brand.

Dietary Supplements

The Company markets and sells a range of propriety supplements through its two wholly owned subsidiaries. Its health supplements include Pristin® MOPL™, which is proven to have a higher nutrient absorption rate over most other marketed products. It can improve overall function of heart, kidneys, liver, lungs, and skin.

Ovine Collagen

Holista is the first to produce ovine collagen from Australian sheep and has also patented the process. Australian sheep are recognised as being disease-free and a culturally acceptable collagen source as opposed to collagen from pigs, cows and other animals.  

The company’s product is highly sought after by cosmetic manufacturers globally.

Corporate Information

company address Level 5, 126 Phillip Street, Sydney NSW 2000, Australia

company phone61 8 63645028

company email[email protected]

company websitehttps://www.holistaco.com/

Dividends

Ex-Dividend Date Franking DPS (AUD) Dividend Yield
30/12/2020 -- 0.000 0.00%
30/12/2019 -- 0.000 0.00%
30/12/2018 -- 0.000 0.00%
30/12/2017 -- 0.000 0.00%
30/12/2016 -- 0.000 0.00%
30/06/2015 -- 0.000 0.00%
30/06/2014 -- 0.000 0.00%
30/06/2013 -- 0.000 0.00%
30/06/2012 -- 0.000 0.00%
30/06/2011 -- 0.000 0.00%

Event Calendar

Event Type Event Date Event Year
Report (Interim) 2022-08-26 2022
Report (Annual) 2022-03-30 2022
Report (Prelim) 2022-02-25 2022

Financials

Breakdown 30/12/2020 30/12/2019 30/12/2018 30/12/2017 30/12/2016
Trading Revenue 7.107 M 7.258 M 7.941 M 7.569 M 3.717 M
Other Revenue 345,334 847,498 177,867 383,998 340,530
Total Revenue 7.452 M 8.105 M 8.118 M 7.953 M 4.057 M
Interest Income 23,405 9,221 16,494 6,302 10,874
Interest Expenses -68,406 -88,820 -83,486 -83,580 -34,032
Expenses -11.811 M -8.905 M -9.872 M -10.853 M -3.736 M
EBITDA -4.359 M -800,139 -1.754 M -2.9 M 320,936
Depreciation and Amortization -220,869 -305,355 -257,378 -224,514 -70,532
Depreciation -195,108 -205,315 -199,186 -224,514 -67,677
Amortisation -25,761 -100,040 -58,192 0 -2,855
EBIT -4.58 M -1.105 M -2.011 M -3.124 M 250,404
Pre Tax Profit -4.625 M -1.185 M -2.078 M -3.201 M 227,246
Tax Expense -86,587 -126,335 -125,082 160,218 -63,388
Net Profit After Tax -4.712 M -1.311 M -2.203 M -3.041 M 163,858
Minority Interest 197,400 214,183 591,213 143,978 2,410
Preference Dividend 0 0 0 0 0
Net Abnormal Items -968,741 407,394 0 -132,988 0
Reported Net Profit After Abnormal Items -5.483 M -689,851 -1.612 M -3.03 M 166,268
Ending Shares 275.349 M 234.039 M 234.039 M 184.039 M 171.709 M
Weighted Average Shares 269.328 M 234.039 M 206.709 M 179.185 M 184.742 M
EPS After Abnormal Items (cents) -2.04 -0.29 -0.78 -1.69 0.09
Breakdown 30/12/2020 30/12/2019 30/12/2018 30/12/2017 30/12/2016
Total Current Assets 6.594 M 5.006 M 4.798 M 3.761 M 3.586 M
Total Non Current Assets 1.459 M 2.92 M 2.629 M 3.053 M 2.462 M
Total Assets 8.053 M 7.927 M 7.427 M 6.814 M 6.047 M
Total Current Liabilities 2.621 M 3.537 M 2.333 M 2.796 M 2.404 M
Total Non Current Liabilities 788,369 819,673 530,407 533,929 533,636
Total Liabilities 3.409 M 4.357 M 2.864 M 3.33 M 2.938 M
Net Assets 4.644 M 3.57 M 4.564 M 3.484 M 3.109 M
Breakdown 30/12/2020 30/12/2019 30/12/2018 30/12/2017 30/12/2016
Net Operating Cash -3.868 M -160,975 -2.2 M 240,922 689,208
Net Invested Cash -80,746 15,209 -204,134 -564,313 -919,097
Net Financing Cash Flows 6.58 M -117,008 2.631 M 387,655 106,400
Beginning Cash 101,400 357,705 120,982 58,105 348,434
End Cash Position 2.725 M 101,400 357,705 120,982 58,105
Exchange Rate Adjustments -7,318 6,469 10,172 -1,387 -166,840
Other Cash Adjustments 0 0 0 0 0
Ending Cash 2.725 M 101,400 357,705 120,982 58,105

© Morningstar, Inc. 2021. All rights reserved. Neither Morningstar, its affiliates, nor the content providers guarantee the market indices, commodities and regulatory news headlines, and other data or content contained herein to be accurate, complete, or timely, and nor shall they have any liability for its use or distribution. The data contained herein: (1) is proprietary to Morningstar and/or its affiliates (collectively, “Morningstar”) and/or their content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete, or timely. Our publications, ratings and products should be viewed as an additional investment resource, and not as your sole source of information. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your financial situation, contact a professional financial adviser. Some material is copyrighted and published under licence from ASX Operations Pty. Ltd. ACN 004523782.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK